232 related articles for article (PubMed ID: 31426476)
21. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.
Christian SL; Collier TW; Zu D; Licursi M; Hough CM; Hirasawa K
J Virol; 2009 Jul; 83(13):6717-26. PubMed ID: 19386709
[TBL] [Abstract][Full Text] [Related]
22. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
23. Seneca Valley virus 3C
Song J; Guo Y; Wang D; Quan R; Wang J; Liu J
J Virol; 2023 Oct; 97(10):e0072723. PubMed ID: 37819133
[TBL] [Abstract][Full Text] [Related]
24. STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling.
Xiang Q; Yang Z; Nicholas J
PLoS Pathog; 2022 Jul; 18(7):e1010676. PubMed ID: 35776779
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of interferon regulatory factor 9 (IRF9).
Paul A; Ismail MN; Tang TH; Ng SK
Mol Biol Rep; 2023 Apr; 50(4):3909-3917. PubMed ID: 36662450
[TBL] [Abstract][Full Text] [Related]
26. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
27. Expression regulation of zebrafish interferon regulatory factor 9 by promoter analysis.
Shi J; Zhang YB; Zhang JS; Gui JF
Dev Comp Immunol; 2013 Dec; 41(4):534-43. PubMed ID: 23916490
[TBL] [Abstract][Full Text] [Related]
28. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
[TBL] [Abstract][Full Text] [Related]
29. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription.
Platanitis E; Demiroz D; Schneller A; Fischer K; Capelle C; Hartl M; Gossenreiter T; Müller M; Novatchkova M; Decker T
Nat Commun; 2019 Jul; 10(1):2921. PubMed ID: 31266943
[TBL] [Abstract][Full Text] [Related]
30. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.
Maiwald T; Schneider A; Busch H; Sahle S; Gretz N; Weiss TS; Kummer U; Klingmüller U
FEBS J; 2010 Nov; 277(22):4741-54. PubMed ID: 20964804
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
Urin V; Shemesh M; Schreiber G
J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
[TBL] [Abstract][Full Text] [Related]
32. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
33. The lack of either IRF9, or STAT2, has surprisingly little effect on human natural killer cell development and function.
Calvo-Apalategi A; Nevado ML; Bravo-Gallego LY; González-Granado LI; Allende LM; Pena RR; López-Granados E; Reyburn HT
Immunology; 2024 Jul; 172(3):440-450. PubMed ID: 38514903
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts.
Sobhkhez M; Skjesol A; Thomassen E; Tollersrud LG; Iliev DB; Sun B; Robertsen B; Jørgensen JB
FEBS Open Bio; 2014; 4():858-71. PubMed ID: 25379383
[TBL] [Abstract][Full Text] [Related]
35. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
Hofer MJ; Li W; Lim SL; Campbell IL
J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
[TBL] [Abstract][Full Text] [Related]
36. Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.
Zhu X; Wang D; Zhou J; Pan T; Chen J; Yang Y; Lv M; Ye X; Peng G; Fang L; Xiao S
J Virol; 2017 May; 91(10):. PubMed ID: 28250121
[TBL] [Abstract][Full Text] [Related]
37. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
38. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9.
Laver T; Nozell SE; Benveniste EN
J Interferon Cytokine Res; 2008 Jan; 28(1):13-23. PubMed ID: 18370868
[TBL] [Abstract][Full Text] [Related]
39. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
Tsuno T; Mejido J; Zhao T; Schmeisser H; Morrow A; Zoon KC
J Immunother; 2009 Oct; 32(8):803-16. PubMed ID: 19752753
[TBL] [Abstract][Full Text] [Related]
40. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.
Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH
Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
